KLOW

Description

KLOW is a multi-peptide blend combining TB4 (10 mg), BPC-157 (10 mg), KPV (10 mg), and GHK-Cu (50 mg) for a total of 80 mg per vial. TB-500 (synthetic thymosin beta-4) promotes wound healing, angiogenesis, and tissue repair. BPC-157 exhibits regenerative properties with preclinical evidence supporting tendon, ligament, and muscle healing. KPV is an anti-inflammatory tripeptide that modulates NF-κB signaling. GHK-Cu supports collagen synthesis, wound healing, and tissue regeneration.